SCHEMBL24521445

SCHEMBL24521445

Cc1ccc(C)c(-c2cc[nH]n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
MAPT P10636 5/20 0.39
HPGD P15428 5/20 0.39
ALOX15 P16050 2/20 0.39
USP2 O75604 1/20 0.39
IDO1 P14902 1/20 0.38
AR P10275 1/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
LMNA P02545 2/20 0.36
GAA P10253 2/20 0.36
HSD17B10 Q99714 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
RECQL P46063 1/20 0.36
TP53 P04637 1/20 0.36
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29785807 0.81 PLA2G7 (0.42) MEN1KMT2AMAPTHPGDIDO1
SCHEMBL13963717 0.81 NISCH (0.45) MEN1KMT2AMAPTHPGDALOX15
SCHEMBL13523179 0.81 HPGD (0.53) MEN1KMT2AMAPTHPGDALOX15
SCHEMBL31645039 0.81 RAB9A (0.34) MEN1KMT2AMAPTHPGDALOX15
SCHEMBL15079440 0.81 IDO1 (0.58) IDO1ARJAK2
SCHEMBL3847656 0.78 MEN1 (0.37) MEN1KMT2AMAPTHPGDALOX15
SCHEMBL28242325 0.78 PRMT5 (0.36) MEN1KMT2AMAPTHPGDAR
SCHEMBL20247777 0.76 NOTUM (0.40) IDO1JAK2
SCHEMBL11624680 0.76 IDO1 (0.53) MEN1KMT2AMAPTHPGDALOX15
SCHEMBL7176525 0.75 MAPK14 (0.43) ARALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135152-A1 PIKFYVE KINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-04 US disclosed
US-20230135152-A1 PIKFYVE KINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-04 US disclosed
EP-3596072-B1 PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230135152-A1 PIKFYVE KINASE INHIBITORS PIKFYVE, PIP5K1B, PIP5K1C MEN1 2087/4885KMT2A 2457/4885MAPT 1501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.